TN-ASENTINEL/ANATOLE
Asentinel, LLC, a Marlin Equity Partners portfolio company, is pleased to announce that it has acquired Anatole, a leading provider of SaaS telecom and IT expense management solutions that help customers reduce costs by auditing and managing services and IT assets. Anatole’s SaaS Telecom Expense Management (TEM) solution unifies mobile, fixed and data telecom services management on a single software platform, and seamlessly integrates with advanced Mobile Device Management (MDM) solutions as well as real-time TEM solutions to monitor employee roaming and smartphone application usage. Anatole is headquartered in Paris, France and has employees in the UK, Germany and Belgium. The merger will add robust wireless capabilities to Asentinel’s existing TEM product offering and create a global, market leading provider of wireline and wireless technology expense management software solutions.
"For 16 years, Anatole's success has resulted from our team's passion to exceed clients' expectations. Our clients know that there is no substitute for local staff with proven expertise in the nuances of the European market," said Raphael Vergnaud, Managing Director of Anatole. "Combining with Asentinel allows us to fulfill our dreams to deliver excellence in telecom expense management and IT expense management around the globe."
“Anatole has distinguished itself as a TEM leader in a complex and shifting European marketplace,” said Tim Whitehorn, Chief Executive Officer of Asentinel. “With the addition of Anatole, we are now well-positioned to respond to the challenges of telecom expense management and mobility in a rapidly growing global market.”
About Anatole
Anatole provides solutions allowing
enterprises to deal with key aspects of telecoms, mobility and IT: cost,
policy, usage and assets. Anatole offers a market-leading TEM solution
and a management suite for analytics, reporting and management of all
telecoms and IT assets, including enterprise mobility solutions and
other user/asset systems.
Anatole offers a complete range of solutions, from software, to consulting, to managed and professional services. Anatole manages telecom spend in more than 50 countries throughout the world; and over 150 customers rely on Anatole solutions. Anatole works directly with enterprises as well as mobile operators and systems integrators. For more information, please visit: www.anatole.net/en .
About Asentinel
Asentinel, a leading provider in Technology
and Telecom Expense Management (TEM) and Managed Mobility Services
(MMS), meets the needs of customers by providing lifecycle solutions and
services delivered through a customer-focused, technology-driven SaaS
platform. Asentinel holds the only comprehensive United States patents
in TEM for its groundbreaking software. The company serves a growing
client base of Global 2000, Fortune 1000 and multinational entities that
rely on the power of TEM and MMS to reduce spend, automate processes,
manage inventory and maximize business intelligence and actionable
analytics. For more information, please visit: www.asentinel.com
.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160602005816/en/
Contact:
For additional information
Asentinel
Jenny Wallace, (901)
312-6514
jenny.wallace@asentinel.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 22:32:00 CEST | Press release
Successful Transaction Marks Another Milestone in A-CAP’s Soccer Club Portfolio Strategy Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 20:00:00 CEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release
- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc
Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release
IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom